Pierre Beaurang

NRIX

Pierre Beaurang serves as Chief Business Officer at Nurix Therapeutics, Inc. (NRIX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$1.30M

Net Position

Net Seller

$1.30M

Companies Traded

NRIX

Active Period

Mar 2021 – Aug 2021

6 total trades

Most Recent

Sell NRIX

Aug 11, 2021 · $223.9K

Pierre Beaurang's Insider Trading at Nurix Therapeutics, Inc. (NRIX)

Buys

0 · $0.00

Sells

6 · $1.30M

Total Shares Bought

Total Shares Sold

45,000

NRIX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 11, 2021	Sell	7,500	$29.86	$223.9K	6,210
Jul 12, 2021	Sell	7,500	$23.92	$179.4K	4,730
Jun 11, 2021	Sell	7,500	$29.37	$220.2K	5,830
May 11, 2021	Sell	7,500	$26.49	$198.6K	7,531
Apr 13, 2021	Sell	7,500	$27.28	$204.6K	7,758
Mar 9, 2021	Sell	7,500	$37.02	$277.7K	4,690

Related Insiders

Gwenn Hansen

officer: Chief Scientific Officer

NRIXSell · Jul 30, 2026

Christine Ring

officer: Chief Legal Officer

NRIXSell · Jul 30, 2026

Houte Hans van

officer: Chief Financial Officer

NRIXSell · Jul 30, 2026

Explore More Insider Trading Data

NRIX Insider Trading Activity

View all insider trades at Nurix Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity